Showing results (431-440 of 671) with videos related to

Sort By:
Pageof 68
The Journal of Clinical Investigation|January 12, 2018
The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA networkXiaochao Tan, Priyam Banerjee, Xin Liu, et al.
Clinical Lung Cancer|June 11, 2014
Vandetanib and indwelling pleural catheter for non-small-cell lung cancer with recurrent malignant pleural effusionErminia Massarelli, Amir Onn, Edith M Marom, et al.
Cancer Research|May 6, 2025
The Integrated Stress Response Pathway Coordinates Translational Control of Multiple Immune Checkpoints in Lung CancerShayna Thomas-Jardin, Shruthy Suresh, Ariana Arce, et al.
Cancer Discovery|July 11, 2013
DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transitionNanyue Chen, Seetharaman Balasenthil, Jacquelyn Reuther, et al.
Plos One|October 15, 2009
Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cellsJunichi Soh, Naoki Okumura, William W Lockwood, et al.
Oncogene|October 4, 2016
ZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasisD H Peng, C Ungewiss, P Tong, et al.
International Journal of Molecular Sciences|February 24, 2024
Circulating microRNA Panel for Prediction of Recurrence and Survival in Early-Stage Lung AdenocarcinomaMei-Chee Tai, Leonidas E Bantis, Gargy Parhy, et al.
Science Translational Medicine|March 15, 2019
ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanismDavid H Peng, Samrat T Kundu, Jared J Fradette, et al.
Plos One|July 7, 2011
Elevated BCRP/ABCG2 expression confers acquired resistance to gefitinib in wild-type EGFR-expressing cellsYun-Ju Chen, Wei-Chien Huang, Ya-Ling Wei, et al.
Cancer Research|July 5, 2011
Increased VEGFR-2 gene copy is associated with chemoresistance and shorter survival in patients with non-small-cell lung carcinoma who receive adjuvant chemotherapyFei Yang, Ximing Tang, Erick Riquelme, et al.
Pageof 68